Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
US8202688B2 · kind B2 · utility
11Cited by
103References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 20, 2002 |
| Grant date | Jun 19, 2012 |
| Priority date | — |
| Expiry date | Nov 28, 2024 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates generally to adjuvants, and in particular to methods and products utilizing a synergistic combination of immunostimulatory oligonucleotides having at least one unmethylated CpG dinucleotide (CpG ODN) and a non-nucleic acid adjuvant. Such combinations of adjuvants may be used with an antigen or alone. The present invention also relates to methods and products utilizing immunostimulatory oligonucleotides having at least one unmethylated CpG dinucleotide (CpG ODN) for induction of cellular immunity in infants.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.